S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
OTCMKTS:MKGAF

MERCK Kommanditgesellschaft auf Aktien Stock Forecast, Price & News

$217.82
-0.73 (-0.33%)
(As of 01/21/2022 03:55 PM ET)
Add
Compare
Today's Range
$217.82
$220.50
50-Day Range
$214.66
$262.68
52-Week Range
$149.00
$264.40
Volume
190 shs
Average Volume
285 shs
Market Capitalization
$28.15 billion
P/E Ratio
29.51
Dividend Yield
N/A
Beta
0.75
30 days | 90 days | 365 days | Advanced Chart
Receive MKGAF News and Ratings via Email

Sign-up to receive the latest news and ratings for MERCK Kommanditgesellschaft auf Aktien and its competitors with MarketBeat's FREE daily newsletter.


MERCK Kommanditgesellschaft auf Aktien logo

About MERCK Kommanditgesellschaft auf Aktien

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Headlines

Merck KGaA sees currencies supporting 2019 outlook
May 14, 2019 |  feeds.reuters.com
Merck KGaA agrees $6.5 bln takeover of Versum
April 12, 2019 |  feeds.reuters.com
See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:MKGAF
CIK
N/A
Employees
58,127
Year Founded
N/A

Sales & Book Value

Annual Sales
$20.03 billion
Cash Flow
$43.22 per share
Book Value
$150.40 per share

Profitability

Net Income
$2.27 billion
Pretax Margin
18.24%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$28.15 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
11/11/2021
Today
1/23/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

0.83 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKGAF) Frequently Asked Questions

How has MERCK Kommanditgesellschaft auf Aktien's stock price been impacted by Coronavirus?

MERCK Kommanditgesellschaft auf Aktien's stock was trading at $111.2250 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MKGAF shares have increased by 95.8% and is now trading at $217.82.
View which stocks have been most impacted by COVID-19
.

Are investors shorting MERCK Kommanditgesellschaft auf Aktien?

MERCK Kommanditgesellschaft auf Aktien saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 58,400 shares, an increase of 28.1% from the December 15th total of 45,600 shares. Based on an average daily trading volume, of 500 shares, the days-to-cover ratio is presently 116.8 days.
View MERCK Kommanditgesellschaft auf Aktien's Short Interest
.

How were MERCK Kommanditgesellschaft auf Aktien's earnings last quarter?

MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKGAF) announced its quarterly earnings results on Thursday, November, 11th. The company reported $2.64 earnings per share for the quarter. The company had revenue of $5.86 billion for the quarter. MERCK Kommanditgesellschaft auf Aktien had a net margin of 14.10% and a trailing twelve-month return on equity of 19.01%.
View MERCK Kommanditgesellschaft auf Aktien's earnings history
.

Who are MERCK Kommanditgesellschaft auf Aktien's key executives?

MERCK Kommanditgesellschaft auf Aktien's management team includes the following people:
  • Belén Garijo López, Chairman-Executive Board & CEO
  • Marcus Kuhnert, Chief Financial Officer
  • Maria Rivas, Chief Medical Officer & Senior Vice President
  • Laura Matz, Chief Science & Technology Officer
  • Meeta Gulyani, EVP, Head-Strategy & Business Development

What is MERCK Kommanditgesellschaft auf Aktien's stock symbol?

MERCK Kommanditgesellschaft auf Aktien trades on the OTCMKTS under the ticker symbol "MKGAF."

How do I buy shares of MERCK Kommanditgesellschaft auf Aktien?

Shares of MKGAF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MERCK Kommanditgesellschaft auf Aktien's stock price today?

One share of MKGAF stock can currently be purchased for approximately $217.82.

How much money does MERCK Kommanditgesellschaft auf Aktien make?

MERCK Kommanditgesellschaft auf Aktien has a market capitalization of $28.15 billion and generates $20.03 billion in revenue each year. The company earns $2.27 billion in net income (profit) each year or $7.38 on an earnings per share basis.

How many employees does MERCK Kommanditgesellschaft auf Aktien have?

MERCK Kommanditgesellschaft auf Aktien employs 58,127 workers across the globe.

What is MERCK Kommanditgesellschaft auf Aktien's official website?

The official website for MERCK Kommanditgesellschaft auf Aktien is www.merckgroup.com.

Where are MERCK Kommanditgesellschaft auf Aktien's headquarters?

MERCK Kommanditgesellschaft auf Aktien is headquartered at Frankfurter Strasse 250, Darmstadt 2M, 64293.

How can I contact MERCK Kommanditgesellschaft auf Aktien?

MERCK Kommanditgesellschaft auf Aktien's mailing address is Frankfurter Strasse 250, Darmstadt 2M, 64293. The company can be reached via phone at 496151720, via email at [email protected], or via fax at 49-61-5172-2000.


This page was last updated on 1/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.